跳至主要内容
临床试验/NCT02503865
NCT02503865已完成1 期

Phase 1-2 Study of Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

Nazarbayev University1 个研究点 分布在 1 个国家目标入组 351 人开始时间: 2003年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
351
试验地点
1
主要终点
Systolic/ Diastolic Blood Pressures (mm Hg)

研究概览

简要总结

Metabolic syndrome: aetiology, pathogenesis, diagnosis, clinical management and prognosis

详细描述

Purpose: To create the complex scientifically proved concept of Metabolic syndrome (МS) development based on elaboration of the new methods of clinical diagnostics of МS components and highly effective МS clinical management in comparative studying of clinical, laboratory and cost effectiveness.

Participants and methods: This clinical study included 351 adults (184 female) in the Scientific research institute of cardiology and internal diseases (Almaty, the Republic of Kazakhstan). Statistical analysis was performed using Microsoft Excel-2008 in updating Lapach, Chubenko et al (2000) and SPSS for Windows v.17.0.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • written consent form
  • age> 25 years
  • skinfold thickness > 0,7 cm BP> 130/85 mm Hg or a patient on antihypertensive medications fasting blood glucose > 6.1 mmole/L, or 2-hour postprandial glucose level > 11.1 mmole/L / or a patient with type 2 diabetes blood cholesterol > 5.6 mmole/L possibility of treatment > 6 months follow-up > 1 year

排除标准

  • complete immobilization of a patient (paresis /paralysis)
  • patients with severe concomitant diseases of the kidneys and (or) of the liver
  • early post-operative condition
  • mental illness
  • pregnancy
  • persons who are in prison
  • persons who are in military Armed Forces

研究组 & 干预措施

Conventional Patient group

Active Comparator

Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin

干预措施: Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin (Drug)

"Analimentary detoxication" Weight loss

Experimental

Vegetables and salt diet

干预措施: "Analimentary detoxication" (Dietary Supplement)

结局指标

主要结局

Systolic/ Diastolic Blood Pressures (mm Hg)

时间窗: up to 12 weeks

Systolic and Diastolic Blood Pressures (mm Hg) was measured by manual/automatic tonometery

Blood Glucose Level

时间窗: up to 12 weeks

Fasting blood glucose (FBG) (mmole/L) and Two-hour postprandial glucose (THPG) (mmole/L) were measured.

次要结局

  • Immunoassay Cortisole in Blood(up to 12 weeks)
  • Lipid Profile(up to 12 weeks)
  • Immunoassay Hormones in Blood(up to 12 weeks)

研究者

发起方
Nazarbayev University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kuat Oshakbayev

Primary investigator

Nazarbayev University

研究点 (1)

Loading locations...

相似试验